Vivaxim
Details for Vivaxim vaccine and its components.
Sponsor:
Sanofi-Aventis Australia
Administration route:
Intramuscular injection
Vaccine group:
Combination vaccines
Registered for use in people aged ≥16 years.
Combination hepatitis A and typhoid vaccine
Supplied in a dual-chamber syringe that enables the 2 vaccines to be mixed just before administration.
Each 1.0 mL dose of mixed vaccine contains:
- 160 antigen units of inactivated hepatitis A virus (GBM strain)
- 25 µg purified Vi capsular polysaccharide of Salmonella typhi strain Ty2
- 0.3 mg aluminium as aluminium hydroxide
- 2.5 µL phenoxyethanol
- 12.5 µg formaldehyde
- ≤5 µg neomycin
- <10 ng bovine serum albumin
- traces of polysorbate 80
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/vivaxim.